Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001437749-22-020846

Options or other derivatives

  • Chief Executive Officer acquired 313,225 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kummeth Charles R. Chief Executive Officer 2022-08-15 Grant or award · Restricted Stock Units +13,225 13,225 D
Kummeth Charles R. Chief Executive Officer 2022-08-15 Grant or award · Stock Options (Right to Buy) +300,000 300,000 D
Loading xslF345X03/rdgdoc.xml…